⌘K

Login Start Free

Home/Filings/4/0001822629-25-000004

4//SEC Filing

Lalwani Nikhil 4

Accession 0001822629-25-000004

CIK 0001023024other

View on SEC.gov Company Profile

Filed

Mar 3, 7:00 PM ET

Accepted

Mar 4, 5:10 PM ET

Size

5.1 KB

Accession

0001822629-25-000004

Insider Transaction Report

Form 4

Period: 2025-02-28

ANI PHARMACEUTICALS INCANIP

DirectorPRESIDENT & CEO

Transactions

Tax Payment
Common Stock
2025-02-28$61.89/sh−12,216$756,048→ 502,694 total

Footnotes (1)

[F1]Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 23,882 shares of restricted stock, the grant of which was previously reported.

Documents

1 file

4
wk-form4_1741126197.xmlPrimary
FORM 4

Issuer

ANI PHARMACEUTICALS INC

CIK 0001023024

Entity typeother

Related Parties

1

filerCIK 0001822629

Filing Metadata

Form type: 4
Filed: Mar 3, 7:00 PM ET
Accepted: Mar 4, 5:10 PM ET
Size: 5.1 KB

View on SEC.gov